Cipla has completed the acquisition of a 100% stake in Inzpera Healthsciences Limited.

With this move, Inzpera has now become a wholly-owned subsidiary of Cipla.

This acquisition marks a strategic expansion for Cipla, aimed at bolstering its presence in key segments and integrating Inzpera's capabilities fully into its operations.

While specific financial details of the transaction were not disclosed in this update, the integration of Inzpera is expected to have a positive operational impact, streamlining portfolio management for Cipla.